CVE:VIR Viridium Pacific Group (VIR) Stock Price, News & Analysis C$0.38 +0.02 (+5.56%) As of 06/7/2019 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Viridium Pacific Group Stock (CVE:VIR) Get Viridium Pacific Group alerts:Sign Up Key Stats Today's RangeC$0.37▼C$0.4150-Day RangeC$0.38▼C$0.3852-Week RangeC$0.36▼C$1.15Volume26,500 shsAverage Volume92,632 shsMarket CapitalizationC$37.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada. Read More Receive VIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VIR Stock News HeadlinesHannover Re to exit Viridium consortium, while Santander Insurance buys inAugust 1, 2025 | reuters.comCinven Sells Viridium to Allianz-Led Consortium for $3.8 BillionMarch 19, 2025 | msn.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.July 5 at 1:00 AM | Profits Run (Ad)Global Insurer Allianz in Talks for $3 Billion-Plus Viridium DealMarch 7, 2025 | msn.comOrchids Are Highly Prized in the West. In the South Pacific, They’re Everywhere.November 14, 2024 | nytimes.comPacific American Holdings Acquires High-Grade Silver ProjectOctober 28, 2024 | msn.comPacific American Holdings Acquires Promising Silver ProjectOctober 25, 2024 | markets.businessinsider.comPacific Urban Investors acquires Cupertino apartmentsOctober 22, 2024 | bizjournals.comSee More Headlines VIR Stock Analysis - Frequently Asked Questions How have VIR shares performed this year? Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2026. Since then, VIR shares have increased by 0.0% and is now trading at C$0.38. How do I buy shares of Viridium Pacific Group? Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Viridium Pacific Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolCVE:VIR CIKN/A Webwww.viridiumpacific.com Phone604-837-8688FaxN/AEmployees580Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.28 Quick Ratio9.91 Sales & Book Value Annual SalesC$1.09 million Price / Sales34.46 Cash FlowC$0.13 per share Price / Cash Flow2.92 Book ValueC$0.29 per share Price / Book1.30Miscellaneous Outstanding Shares98,733,000Free FloatN/AMarket CapC$37.52 million OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (CVE:VIR) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridium Pacific Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridium Pacific Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
